تحذيرات السلامة

#	العنوان	نوع الخبر	التاريخ
72	SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19	Warning	2020-04-24
71	SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19	Precautions	2020-04-14
70	SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19	Precautions	2020-03-31
69	Risk of potentially fatal respiratory depression with benzodiazepines and opioids	Warning	2020-03-22
68	Concern on Potential Risk of Respiratory Depression Associated with Gabapentinoids (pregabalin and gabapentin) medications	Warning	2020-01-23
67	Ceftriaxone: a reminder for the risk of hypersensitivity	Warning	2019-12-24
66	Concerns on paracetamol overdose in children	Warning	2019-11-29
65	Risk of neuropsychiatric reactions with the use of Montelukast	Warning	2019-10-11
64	Risk of Myocarditis Associated With the Use of Atezolizumab	Warning and Precaution	2018-10-23
63	Nivolumab	Precautions	2018-10-03